Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 1/20 | 0.46 |
| ▸ | GABRD | O14764 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11896840 | 1.00 | LMNA (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL2461935 | 0.97 | LMNA (0.53) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL2468753 | 0.97 | LMNA (0.53) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL112741 | 0.97 | LMNA (0.59) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL14761645 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL2459523 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL2456770 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL2462143 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL14761768 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL14761489 | 0.95 | PRMT1 (0.56) | LMNASLC22A6TSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130210922-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNIPHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2013-08-15 | — | — | US | claimed |
| WO-2011144335-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2011-11-24 | — | — | WO | claimed |
| EP-0804455-A4 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORP (US) | 2000-01-12 | — | — | EP | claimed |
| US-5726021-A | PRETREATING CELLS BY ENZYME DEGRADATION, MAGNESIUM CHELATORS, NONIONIC AND ANIONIC DETERGENTS AND HEATING | BECTON DICKINSON AND COMPANY (US) | 1998-03-10 | — | — | US | claimed |
| EP-0804455-A1 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORPORATION (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1995034574-A1 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORPORATION (US) | 1995-12-21 | — | — | WO | claimed |
| CN-107670027-B | Compositions and methods for treating skin conditions | ZO皮肤健康公司 | 2023-05-19 | — | — | CN | disclosed |
| CN-114080236-A | Compositions and methods for treating biofilm-associated pulmonary conditions | 轨迹IP有限责任公司 | 2022-02-22 | — | — | CN | disclosed |
| US-20130210922-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNIPHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2013-08-15 | — | — | US | disclosed |
| EP-2389923-B1 | Stable ready to use injectable paracetamol formulation | UNI PHARMA KLEON TSETIS PHARMACEUTICAL LAB S A (GR) | 2013-01-30 | — | — | EP | disclosed |
| US-20110318290-A1 | Compounds and Methods for Inhibiting Axillary Malodour | GIVAUDAN SA (CH) | 2011-12-29 | — | — | US | disclosed |
| EP-2389923-A1 | Stable ready to use injectable paracetamol formulation | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) | 2011-11-30 | — | — | EP | disclosed |
| WO-2011144335-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2011-11-24 | — | — | WO | disclosed |
| WO-2002092024-A2 | COMPOUNDS AND METHODS FOR INHIBITING AXILLARY MALODOUR | GIVAUDAN SA (CH) | 2002-11-21 | — | — | WO | disclosed |
| EP-0804455-A4 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORP (US) | 2000-01-12 | — | — | EP | disclosed |
| US-5770373-A | Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors | BECTON DICKINSON AND COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5726021-A | PRETREATING CELLS BY ENZYME DEGRADATION, MAGNESIUM CHELATORS, NONIONIC AND ANIONIC DETERGENTS AND HEATING | BECTON DICKINSON AND COMPANY (US) | 1998-03-10 | — | — | US | disclosed |
| US-5712095-A | Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors | BECTON DICKINSON AND COMPANY (US) | 1998-01-27 | — | — | US | disclosed |
| EP-0804455-A1 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORPORATION (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1995034574-A1 | RAPID AND SENSITIVE DETECTION OF ANTIBIOTIC-RESISTANT MYCOBACTERIA USING OLIGONUCLEOTIDE PROBES SPECIFIC FOR RIBOSOMAL RNA PRECURSORS | MICROPROBE CORPORATION (US) | 1995-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110318290-A1 | Compounds and Methods for Inhibiting Axillary Malodour | TYR, AOX1, APEH | LMNA 4807/4885SLC22A6 3410/4885TSHR 2615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.